Insights

4 Major Implications of Cannabis Moving to Schedule III

By Andrew Livingston, Jason Adelstone, Shawn Hauser
Apr 30, 2024

After 50 years of being in the most restrictive schedule alongside drugs like heroin and PCP, the DEA will move to reschedule marijuana from Schedule I to Schedule III, where the plant’s medical benefits will finally be recognized by the federal government. Read this article for answers to four of the most important questions about the effects Schedule III will have on cannabis and society.

Read More

Colorado Natural Medicine Advisory Bulletin #11: March & April 2024

By Vicente LLP, Psychedelic Alpha
Apr 30, 2024

Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #11 features summaries of the draft rules covering licensing and financial interests and general/operational rules, the stakeholder meeting feedback on those rules, and notes from the combined subcommittee meeting on April 12 and the full Natural Medicine Advisory Board meeting on April 19.

Read More

Marijuana Rescheduling: Why Opponents Have No Idea What They Are Talking About

By Jason Adelstone
Apr 29, 2024

After listening to the House Oversight and Accountability Committee Hearing with the Commissioner of the FDA on April 11, one conclusion was reinforced—opponents of marijuana reform are misinformed and rely on misstating facts to support their position. Those against moving marijuana into schedule III are making their voices heard, but almost universally, those voices simply do not understand what schedule III would mean.

Read More

Colorado Natural Medicine Program Draft Rules Released And Public Hearing Scheduled

By Barine Majewska
Apr 24, 2024

DORA recently presented additional draft rules for Colorado’s regulated natural medicine market to the Natural Medicine Advisory Board, focused on facilitator conduct and relationships, administrative sessions, informed consent, record keeping and advertising. DORA will host a virtual public hearing on the new rules on April 26 and the Natural Medicine Division of the Department of Revenue will host a stakeholder meeting on Healing Center requirements on May 1. These are important opportunities to make your voices heard! Read this article for details on the rules and instructions for joining the meetings.

Read More

Kentucky Medical Cannabis Licensing Update: New Bill and Regulations

By Yolanda Clarke, Colleen Mitchell
Apr 19, 2024

In an exciting week for the nascent Kentucky medical cannabis program, interested stakeholders were provided abundant new information to inform their business goals. Read this article for details on the new bill and regulations, and key licensing details—including medical cannabis business license caps.

Read More

WELCOME TO VICENTE INSIGHTS!

Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.

Subscribe to RSS

POPULAR TOPICS